Hybio Pharmaceutical Co., Ltd. (SHE:300199)

China · Delayed Price · Currency is CNY

22.67

-0.81 (-3.45%)

Aug 26, 2026, 3:04 PM CST

Hybio Pharmaceutical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	1,105	966.35	590.2	431.38	704.32	735.97
Revenue Growth	25.03%	63.73%	36.81%	-38.75%	-4.30%	1.97%
Gross Profit	632.36	539.12	308.73	170.97	509.49	464.1
Operating Income	219.6	168.34	-32.41	-371.41	-182.13	-270.27
Net Income	127.8	36.57	-173.65	-513.88	-370.55	30.81
Earnings Per Share	0.14	0.04	-0.20	-0.58	-0.42	0.03
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
China	367.93	265.02	319.17	625.06	689.03
Foreign	598.42	325.18	112.21	79.26	46.94
Total	966.35	590.2	431.38	704.32	735.97

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	150.79	101.95	95.97	344.01	266.83	616.6
Total Debt	1,914	1,910	1,798	2,030	1,806	1,789
Net Cash (Debt)	-1,763	-1,808	-1,702	-1,686	-1,540	-1,173
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.96	-1.98	-1.96	-1.90	-1.74	-1.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	382.22	233.9	164.71	-3.54	15.81	156.83
Capital Expenditures	-360.3	-234.35	-115.84	-81.76	-189.85	-199
Free Cash Flow	21.92	-0.45	48.87	-85.3	-174.04	-42.17
Free Cash Flow Growth	-84.18%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	57.22%	55.79%	52.31%	39.63%	72.34%	63.06%
Operating Margin	19.87%	17.42%	-5.49%	-86.10%	-25.86%	-36.72%
Pretax Margin	14.30%	6.65%	-27.52%	-118.48%	-52.93%	4.58%
Profit Margin	11.56%	3.78%	-29.42%	-119.12%	-52.61%	4.19%
FCF Margin	1.98%	-0.05%	8.28%	-19.77%	-24.71%	-5.73%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	159.29	432.32	-	-	-	361.52
Forward PE	-	9.21	9.21	9.21	9.21	9.21
P/FCF Ratio	913.66	-	232.96	-	-	-
PS Ratio	18.12	16.36	19.29	27.80	22.05	15.13